As AbbVie moved away from promotional spend on its aging megablockbuster Humira at the same time Sanofi and Regeneron stepped up their TV campaigns for Dupixent in 2021, you might be forgiven for ...
The end of 2022 was when over-the-counter drug advertisers put their money where their mouth was when it came to ad spend and the numbers bare it out. Vicks achieved an impressions share of voice (SOV ...
Dupixent is back in the driver’s seat, reclaiming the top spot for ad impressions among Rx and over-the-counter (OTC) brands in May. The eczema and asthma drug from Sanofi and Regeneron had an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback